
European Journal of Medicinal Chemistry p. 957 - 967 (1998)
Update date:2022-08-04
Topics:
Caliendo, Giuseppe
Grieco, Paolo
Perissutti, Elisa
Santagada, Vincenzo
Santini, Antonello
Albrizio, Stefania
Fattorusso, Caterina
Pinto, Aldo
Sorrentino, Raffaella
With the aim of discovering new molecules with K+-channel activating properties, we have synthesized derivatives of cromakalim (CRK), an important molecule which shows specific affinity towards K+ channels, by replacing the benzopyrane ring of this reference compound with a 1,4-benzoxazine moiety. A different number of substituents showing a good discrimination between hydrophobic and electronic properties have been inserted at the 6-position of the 1,4-benzoxazine ring. We describe here the synthesis and discuss the solid state conformation of these new molecules. When tested on rat aorta ring precontracted with phenylephrine, two compounds (2c and 2d) showed a concentration-dependent relaxation similar to that measured for cromakalim but less potent than this reference drug.
View MoreSuzhou Chenke Biotech Co., Ltd.
Contact:+86-18662408853
Address:NO.150, Renai Road, Suzhou Industrial Park
Anhui Xinyuan Technology Co.,Ltd
Contact:0086-559-3515800
Address:No.16 Zijin Rd, Circular Economic Zone, Huizhou District, Huangshan Anhui China
Shanghai Forever Biotech Co., Ltd.
Contact:+86-21-69734790
Address:Room 5017/5019、5022、5024 of Technology Innovation Centre, No.1155, Gongyuan East Rd, QingPu District, Shanghai China.
Xi'an HO-SHINE Bio-Technology Co., Ltd
Contact:+86 (29) 8248-5435/18292020086
Address:No.6 Shiyuan Road Xian City Shaanxi Province, 710048 China
Tianjin Jingye Fine Chemicals Co., Ltd.
Contact:+86-15722078107; +86-22-26911407
Address:Bohua Fine Chemicals Base of Petrochemical Industry Park, Nanhuan Road, Dagang District, Tianjin, 300271, P. R. China
Doi:10.1021/jo00838a036
(1969)Doi:10.1071/CH9951873
(1995)Doi:10.1016/0040-4039(95)01518-3
(1995)Doi:10.1021/om950574q
(1996)Doi:10.1021/ja00151a030
(1995)Doi:10.1055/s-2006-942359
(2006)